Perioperative Sedative Drug Delivery: Formulation and Pharmacokinetic Considerations with Emphasis on Intravenous and Alternate Routes
International Journal of Drug Delivery Technology · 25.04.2026 · 16 (20s)
DOI: 10.25258/ijddt.16.20s.43 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 25.04.2026. Verfasst von Dr. Bhavya Sharma und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Perioperative sedation constitutes with a critical component of various modern surgical and procedural care, requiring precise control over the onset, depth, as well as the recovery profiles. The route of sedative drug assay is critically important on the pharmacodynamics, pharmacokinetics and the patient final outcome. The most popular one is I.V. pipetting due to its rapid absorption, predictable bioavailability and titration. However, noninvasive routes such as intranasal, oral, sublingual and incorporation routes, as well as transdermal route of administration has proven to be used as alternative routes of administration with their application in specific sections of clinical population having received attention. The strategies of formulations and pharmacokinetic principles of administration of sedative drugs in perioperative procedures are discussed in this paper referring to the rapid-onset and rapid-offset agents. A relative comparison is conducted between intravenous and nonintravenous route on the aspects of absorption kinetics, distribution, metabolism, elimination and clinical efficacy. The study also uses the new pharmacological advances, which comprise lipid-based systems, nanocarriers, and prodrug delivery that boost the drug delivery and therapeutic mechanisms. The findings indicate that although intravenous administration is superior in terms of control and immediacy, alternative routes are becoming increasingly important in ambulatory practice, pediatric sedation, and resource constrained practice. Formulation innovations are the way through bioavailability limitations and enhancement of onset properties of the non-iv administration. The study establishes that the decision on the route must rely on procedural factors, patient-associated factors, and the pharmacokinetic nature of the drug.
Zitieren
APA
Sharma, D. B., & Devi, D. L. (2026). Perioperative Sedative Drug Delivery: Formulation and Pharmacokinetic Considerations with Emphasis on Intravenous and Alternate Routes. International Journal of Drug Delivery Technology, 16(20s). https://doi.org/10.25258/ijddt.16.20s.43
Vancouver
Sharma DB, Devi DL. Perioperative Sedative Drug Delivery: Formulation and Pharmacokinetic Considerations with Emphasis on Intravenous and Alternate Routes. International Journal of Drug Delivery Technology. 2026;16(20s). doi:10.25258/ijddt.16.20s.43
BibTeX
@article{Sharma2026,
author = {Sharma, Dr. Bhavya and Devi, Dr. Lata},
title = {Perioperative Sedative Drug Delivery: Formulation and Pharmacokinetic Considerations with Emphasis on Intravenous and Alternate Routes},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {20s},
doi = {10.25258/ijddt.16.20s.43}
}
EUVIMED